CIK 0001075880
- Accelerated filer
KAZIA THERAPEUTICS LTD
Sign in to watch- Ticker
- KZIA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- Australia
- Entity type
- Operating
- Phone
- +61 298780088
- Business address
- THREE INTERNATIONAL TOWERS LEVEL 24,, 300 BARANGAROO AVENUE, SYDNEY NSW, Australia, 2000
- Former names
- NOVOGEN LTD
- 4 Open-market buy 10% owner bought 9,945 shares at an average $9.14 ($90,914)
- 4 Open-market buy 10% owner bought 7,700 shares at $9.63 ($74,119)
- 4 Open-market buy 10% owner bought 10,000 shares at $9.23 ($92,256)
- 4 Open-market buy 10% owner bought 9,100 shares at an average $9.09 ($82,716)
- 4 Open-market buy 10% owner bought 15,200 shares at an average $9.24 ($140,422)
- 4 Open-market buy 10% owner bought 8,000 shares at $9.27 ($74,178)
- 4 Open-market buy 10% owner bought 18,875 shares at an average $9.54 ($180,021)
- 4 Open-market buy 10% owner bought 1,510 shares at $9.98 ($15,070)
- 4 Open-market buy 10% owner bought 23,000 shares at $9.93 ($228,328)
- 4 Open-market buy 10% owner bought 8,914 shares at $9.97 ($88,873)
- 4 Open-market buy 10% owner bought 10,000 shares at an average $9.97 ($99,681)
- 4 Open-market buy 10% owner bought 13,000 shares at $9.88 ($128,488)
- 4 Open-market buy 10% owner bought 18,202 shares at an average $9.86 ($179,421)
- 4 Open-market buy 10% owner bought 1,758 shares at an average $9.64 ($16,950)
- 4 Open-market buy 10% owner bought 4,583 shares at an average $9.82 ($45,007)
- 4 Open-market buy 10% owner bought 3,300 shares at an average $10.00 ($32,999)
- 4 Open-market buy 10% owner bought 6,000 shares at an average $9.92 ($59,534)
- 4 Open-market buy 10% owner bought 3,000 shares at $9.99 ($29,970)
- 4 Open-market buy 10% owner bought 6,100 shares at $11.30 ($68,930)
- 4 Open-market buy Director bought 6,100 shares at $10.42 ($63,561)
Page 3 of 5 · 84 filings